This stock comparison examines GEHC and ROP, two technology-oriented firms navigating distinct market dynamics. GEHC, a leader in medical imaging and patient care solutions, faces headwinds from cost inflation, while ROP, a diversified software and tech holding company, demonstrates resilience through earnings beats and buybacks. Traders seeking sector exposure in healthcare tech versus industrial software, or investors evaluating relative performance and risk in the current environment of volatility and inflation, will find value in this head-to-head analysis of price behavior, growth drivers, and market positioning.
GEHC, or GE HealthCare Technologies Inc., develops and markets medical technologies including imaging systems, ultrasound, patient monitoring, and pharmaceutical diagnostics. Spun off from General Electric in 2023, it serves global healthcare providers with digital solutions for diagnosis and treatment.
In recent market activity, GEHC shares have trended lower, hitting a 52-week low near $59 after a sharp decline around its Q1 earnings release. The stock fell approximately 20% from mid-April highs amid a lowered full-year profit outlook, attributed to rising costs for memory chips, oil, and freight—totaling a $250 million headwind. Restructuring moves, such as combining imaging and advanced visualization into a $14.6 billion segment, aim to boost efficiency. Analyst price target reductions followed, reflecting tempered sentiment, though YTD returns stand at -25.5% with a market cap of $27.8 billion and P/E of 14.6x.
ROP, or Roper Technologies, Inc., is a holding company acquiring and managing niche software and technology-enabled products across application software, network software, and tech products segments. Its portfolio includes firms like Deltek and Vertafore, targeting vertical markets in industrials, energy, and healthcare.
Recent weeks have seen ROP maintain relative stability, with shares fluctuating in the $350-$360 range post-Q1 earnings. The company reported 11% revenue growth to $2.1 billion, beating estimates, and raised full-year diluted earnings per share (DEPS) guidance to $21.80-$22.05. An expanded $3 billion share repurchase authorization signals confidence. Despite a 52-week high of $584, the stock trades at a market cap near $36 billion, buoyed by organic growth and acquisitions, though longer-term YTD performance reflects broader market pressures.
Tickeron’s Trending AI Robots page curates over 25 top-performing AI trading bots from its library of 351 agents that trade thousands of tickers across stocks, ETFs, and crypto. Selected for current market conditions like volatility in semiconductors and AI themes, these bots showcase annualized returns from +23% to +162%, win rates of 51%-88%, and profit factors up to 11.7. Strategies vary from 5-minute scalps using momentum and ML signals to 60-minute trend-following with take-profit/stop-loss (e.g., TP 3%/SL 2%), hedging via double agents, and multi-ticker portfolios (1-18 tickers) in sectors like energy, gold miners, and space imaging. High-conviction bots like the 60min AI Volatility Bot (+162% return, 74.7% win rate) outperform the S&P 500. Explore these diverse styles—short-term scalps to longer swings—to align with your trading timeframe and enhance performance in today's markets.
GEHC and ROP both leverage technology for niche dominance but differ in business models: GEHC's hardware-heavy healthcare focus (imaging, diagnostics) contrasts ROP's asset-light software acquisitions emphasizing recurring revenue.
Growth drivers for GEHC include AI-enhanced imaging and clinical trials like LUMINA for MRI agents, while ROP relies on M&A (mergers and acquisitions) and organic expansion in vertical software. Recent momentum favors ROP's steady trading versus GEHC's post-earnings drop. Risk factors highlight GEHC's exposure to supply chain inflation and healthcare spending cycles, against ROP's integration risks in acquisitions. Sector-wise, GEHC ties to defensive healthcare, ROP to cyclical industrials/tech. Sentiment leans positive on ROP's buybacks amid GEHC's cost pressures.
Tickeron’s AI currently favors ROP over GEHC in short-term stock comparisons, citing superior trend consistency from earnings beats and raised guidance, alongside greater stability via buybacks and software resilience. ROP's relative positioning in diversified tech offers a probabilistic edge amid GEHC's inflationary catalysts, though both warrant monitoring for sector recoveries.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GEHC’s FA Score shows that 0 FA rating(s) are green whileROP’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GEHC’s TA Score shows that 4 TA indicator(s) are bullish while ROP’s TA Score has 5 bullish TA indicator(s).
GEHC (@Medical/Nursing Services) experienced а +2.05% price change this week, while ROP (@Packaged Software) price change was -9.15% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.99%. For the same industry, the average monthly price growth was +2.23%, and the average quarterly price growth was -5.00%.
The average weekly price growth across all stocks in the @Packaged Software industry was -3.28%. For the same industry, the average monthly price growth was +12.08%, and the average quarterly price growth was +77.76%.
ROP is expected to report earnings on Jul 17, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Packaged Software (-3.28% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
| GEHC | ROP | GEHC / ROP | |
| Capitalization | 28.3B | 32.7B | 87% |
| EBITDA | 3.6B | 3.43B | 105% |
| Gain YTD | -23.988 | -26.891 | 89% |
| P/E Ratio | 14.94 | 20.23 | 74% |
| Revenue | 21B | 8.12B | 259% |
| Total Cash | 2.26B | 383M | 590% |
| Total Debt | 10.6B | 10.5B | 101% |
ROP | ||
|---|---|---|
OUTLOOK RATING 1..100 | 75 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 23 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 73 | |
PRICE GROWTH RATING 1..100 | 64 | |
P/E GROWTH RATING 1..100 | 94 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| GEHC | ROP | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 71% | 2 days ago 54% |
| Stochastic ODDS (%) | 1 day ago 71% | 2 days ago 44% |
| Momentum ODDS (%) | 1 day ago 65% | 2 days ago 32% |
| MACD ODDS (%) | 1 day ago 58% | 2 days ago 41% |
| TrendWeek ODDS (%) | 1 day ago 68% | 2 days ago 43% |
| TrendMonth ODDS (%) | 1 day ago 63% | 2 days ago 50% |
| Advances ODDS (%) | 7 days ago 70% | 14 days ago 39% |
| Declines ODDS (%) | 14 days ago 59% | 2 days ago 44% |
| BollingerBands ODDS (%) | 1 day ago 61% | 2 days ago 49% |
| Aroon ODDS (%) | 2 days ago 50% | 2 days ago 26% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AVS | 7.45 | 0.16 | +2.13% |
| Direxion Daily AVGO Bear 1X Shares | |||
| PANG | 13.51 | 0.27 | +2.06% |
| Leverage Shares 2X Long PANW Daily ETF | |||
| EDV | 62.87 | -0.63 | -0.99% |
| Vanguard Extended Duration Trs ETF | |||
| FFTY | 41.46 | -0.54 | -1.29% |
| CapForce IBD® 50 ETF | |||
| DPST | 108.60 | -2.07 | -1.87% |
| Direxion Daily Regional Bnks Bull 3X ETF | |||
A.I.dvisor indicates that over the last year, ROP has been closely correlated with AME. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if ROP jumps, then AME could also see price increases.
| Ticker / NAME | Correlation To ROP | 1D Price Change % | ||
|---|---|---|---|---|
| ROP | 100% | -1.48% | ||
| AME - ROP | 75% Closely correlated | -0.41% | ||
| GGG - ROP | 71% Closely correlated | -0.43% | ||
| IEX - ROP | 69% Closely correlated | -0.07% | ||
| OTIS - ROP | 69% Closely correlated | +0.14% | ||
| NDSN - ROP | 68% Closely correlated | -0.24% | ||
More | ||||